Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4553 reports available
All reports
Page 169 of 188
Spring Forward
TPL Advisory · May 13, 2026
Earnings Review: 1Q Loss Wider on One-Off Capacity Expenses
Goldman Sachs · May 13, 2026
Illuminating the Road Less Traveled in Biotech: Radiopharmaceuticals
William Blair · May 13, 2026
Consumer: The Inverse
Goldman Sachs · May 13, 2026
ASML Holding Catalyst Rich 2026 Bodes Well for Path to €1600 Per Share
Goldman Sachs · May 13, 2026
Asian Equity Market Daily Update
Goldman Sachs · May 13, 2026
Aristocrat Leisure 1H26 First Take
Goldman Sachs · May 13, 2026
Europe Macro and Staples and Retail Conference Update
Goldman Sachs International · May 13, 2026
Americas Small Cap Research Summary
Barclays · May 13, 2026
Nextpower Strong Demand and Execution Drives Beat and Raise
Goldman Sachs · May 13, 2026
European Morning Research Summary
Barclays · May 13, 2026
Vallourec 1Q26 First Take
Goldman Sachs · May 13, 2026
US Generic Drug Pricing Tracker
Goldman Sachs · May 13, 2026
Nobody Owns Enough China
The Market Ear · May 13, 2026
Tyson Foods Global Staples Forum 2026 Key Takeaways
Goldman Sachs · May 13, 2026
International Market Intelligence Morning Briefing
J.P. Morgan · May 13, 2026
Retail Specialty Apparel and Accessories 1Q26 Preview
Goldman Sachs · May 13, 2026
Allianz Results First Take
Goldman Sachs · May 13, 2026
Petrobras Key Takeaways From Earnings Call and Model Update
Goldman Sachs · May 13, 2026
UK Home Builders Expert Call with Knight Frank Key Takeaways
Goldman Sachs · May 13, 2026
ABN Amro Bank Q1 2026 First Look
Goldman Sachs · May 13, 2026
AECOM FY2Q Takeaways Mixed Quarter But Pullback Overdone
Goldman Sachs · May 13, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · May 13, 2026
Australian Morning Focus
ANZ · May 13, 2026